Alerus Financial’s GlucoTrack GCTK Stock Holding History

Alerus Financial’s Portfolio GCTK Stock Details GCTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.6K	Hold	4,000	–	–	﹤0.01%	444
2025 Q4	$15.5K	Sell	4,000 -1,000	-20%	-$5.93K	﹤0.01%	320
2025 Q3	$33K	Buy	+5,000	New	+$30.1K	﹤0.01%	287
2025 Q2	–	Sell	-5,000	Closed	-$52.4K	–	511
2025 Q1	$52.4K	Buy	5,000 +4,988	+41,567%	+$335K	﹤0.01%	158
2024 Q4	$5.17K	Hold	12	–	–	﹤0.01%	157
2024 Q3	$33.4K	Hold	12	–	–	﹤0.01%	155
2024 Q2	$27.8K	Hold	12	–	–	﹤0.01%	156
2024 Q1	$22.9K	Hold	12	–	–	﹤0.01%	160
2023 Q4	$18.1K	Hold	12	–	–	﹤0.01%	150
2023 Q3	$18.2K	Hold	12	–	–	﹤0.01%	152
2023 Q2	$23.9K	Buy	12 +10	+500%	+$35.9K	﹤0.01%	157
2023 Q1	$3.91K	Hold	2	–	–	﹤0.01%	163
2022 Q4	$16.2K	Hold	2	–	–	﹤0.01%	164
2022 Q3	$23K	Buy	+2	New	+$26K	﹤0.01%	150

Other funds holding GCTK

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alerus Financial's GCTK Position: Q1 2026 in Review

Alerus Financial held its GlucoTrack (GCTK) position steady in Q1 2026 at 4,000 shares worth $2.6K. The position accounts for ﹤0.01% of the portfolio, ranked #444.

Alerus Financial first reported a position in GCTK in Q3 2022 and has held it in 14 quarters since. The position peaked at $52.4K in Q1 2025. 13 funds tracked by Wall St. Rank hold GCTK as of Q1 2026.

Alerus Financial held 4,000 shares of GlucoTrack worth $2.6K as of Q1 2026.
Alerus Financial left its GlucoTrack share count unchanged in Q1 2026.
GlucoTrack made up ﹤0.01% of Alerus Financial's portfolio in Q1 2026, its #444 holding.
Alerus Financial first reported a position in GlucoTrack in Q3 2022 and has held it in 14 quarters since.
Alerus Financial's GlucoTrack position peaked at $52.4K in Q1 2025.
13 funds tracked by Wall St. Rank held GlucoTrack as of Q1 2026.

Based on Alerus Financial's 13F filing for Q1 2026, filed 12 May 2026.